Related Articles
GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system
GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway
Detection of mRNA expression of gonadotropin-releasing hormone and its receptor in normal and neoplastic rat prostates
Gonadotropin‑releasing hormone inhibits the proliferation and motility of nasopharyngeal carcinoma cells
Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptor